PDL BioPharma
Article Abstract:
The price appreciation potential of the shares of PDL BioPharma Inc. for the years 2010-2012 is discussed. The Freemont, California-based company offers humanized antibodies and other proteins to prevent or treat various disease conditions.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2007
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
Sanofi-Aventis
Article Abstract:
The price appreciation potential of the shares of Sanofi-Aventis for the years 2010-2012 is discussed. The Bridgewater, New Jersey-based company is the third-largest drug company in the world and the largest in continental Europe.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2008
France, SNY, Sanofi-Aventis S.A., Analyst report
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2008
User Contributions:
Comment about this article or add new information about this topic:
Subjects list: United States, Evaluation, Pharmaceutical industry, Stocks, Securities, Stock prices, Company securities
Similar abstracts:
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.